ME LD 1502
enactedAn Act To Update The Requirements For Health Insurance Coverage Of Prostate Cancer Screening
Maine · 132 · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did ME LD 1502 pass?
Yes. ME LD 1502 has been enacted into law. Latest recorded action (2026-04-15): Signed by Governor
What is ME LD 1502 about?
ME LD 1502 is a bill in the 132 titled “An Act To Update The Requirements For Health Insurance Coverage Of Prostate Cancer Screening”.
Who sponsors ME LD 1502?
Matt MOONEN is the primary sponsor of ME LD 1502, joined by 6 cosponsors.
- Introduced
- —
- Latest action
- 2026-04-15 — Signed by Governor
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Matt MOONENprimary
- Robert FOLEYcosponsor
- Paul FLYNNcosponsor
- Kristi MATHIESONcosponsor
- Donna BAILEYcosponsor
- Anne-Marie MASTRACCIOcosponsor
- Michelle BOYERcosponsor
Committees
Not provided by source.
Action timeline
Newest first
2026-04-15
Signed by Governor
executive-signature
2026-04-13
Subsequently, PASSED TO BE ENACTED in concurrence.
passage
2026-04-13
On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table.
2026-04-06
On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence.
2026-04-02
Sent for concurrence. ORDERED SENT FORTHWITH.
2026-04-02
PASSED TO BE ENACTED.
passage
2026-04-02
Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (H-916) in concurrence.
reading-2,reading-3
2026-04-02
Committee Amendment "A" (H-916) READ and ADOPTED.
committee-passage-favorable
2026-04-02
READ ONCE.
reading-1
2026-04-02
On motion by Senator BAILEY of York the Majority Ought to Pass as Amended Report ACCEPTED.
2026-04-02
Reports READ.
2026-03-30
Sent for concurrence. ORDERED SENT FORTHWITH.
2026-03-30
The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-916).
reading-3
2026-03-30
Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading.
2026-03-30
Committee Amendment "A" (H-916) was READ and ADOPTED.
committee-passage-favorable
2026-03-30
The Bill was READ ONCE.
reading-1
2026-03-30
On motion of Representative MATHIESON of Kittery, the Majority Ought to Pass as Amended Report was ACCEPTED.
2026-03-30
Reports READ.
2026-03-27
Reported Out - OTP-AM/ONTP
2026-01-21
Voted - Divided Report
2026-01-21
Work Session Held
2026-01-14
Work Session Held - TABLED
2025-06-25
Carried over, in the same posture, to any special or regular session of the 132nd Legislature, pursuant to Joint Order SP 800.
2025-05-19
Carry Over Approved
2025-05-16
Carry Over Requested
2025-05-15
Work Session Held - TABLED
2025-05-08
Work Session Held - TABLED
2025-04-08
The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES in concurrence
referral-committee
2025-04-08
Sent for concurrence. ORDERED SENT FORTHWITH.
2025-04-08
The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES.
referral-committee
2025-04-08
Committee on Health Coverage, Insurance and Financial Services suggested and ordered printed.
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-10-22T18:52:12.906381Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=ME&identifier=LD 1502. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.